Search

everythinglearnresearchcommunity

for

Search:↓

Kuntai capsules combined with nilestriol tablets effectively reduce perimenopausal symptoms and improve hormone levels.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Wildebeest stress and hormone levels are influenced by food availability, human presence, and reproductive cycles.

Neutered ferrets often develop hyperadrenocorticism, with symptoms like hair loss and lethargy, and androstenedione is a key indicator for diagnosis.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Females generally have stronger immune responses than males due to the X chromosome.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.